In general, inflammatory pathways are attenuated in the TLR-KO genotype [69], such as cytokine and interleukin signaling and inflammatory processes, as demonstrated after brain injury or diabetes in TLR4-KO [70, 71]. The gene discussed is TLR4; the disease is diabetes mellitus.